Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004581490 | SCV005066817 | pathogenic | Fanconi anemia | 2023-05-13 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 15-31 of the FANCA gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with FANCA-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FANCA protein in which other variant(s) (p.Glu936Gly) have been determined to be pathogenic (PMID: 15643609, 17924555). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. |